131 related articles for article (PubMed ID: 32896257)
1. Prevalence and outcome of thrombocytopenia in systemic lupus erythematous: single-centre cohort analysis.
Costa Pires T; Caparrós-Ruiz R; Gaspar P; Isenberg DA
Clin Exp Rheumatol; 2021; 39(3):601-605. PubMed ID: 32896257
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems.
Sultan SM; Begum S; Isenberg DA
Rheumatology (Oxford); 2003 Feb; 42(2):230-4. PubMed ID: 12595615
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia.
Ahn SM; Choi EJ; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Arthritis Res Ther; 2022 Sep; 24(1):213. PubMed ID: 36068638
[TBL] [Abstract][Full Text] [Related]
4. Severe thrombocytopenia is associated with high mortality in systemic lupus erythematosus-analysis from Indian SLE Inception cohort for Research (INSPIRE).
Shobha V; Rajasekhar L; Bhat V; Mathew AJ; Kavadichanda C; Rathi M; Gupta R; Selvam S; Aggarwal A;
Clin Rheumatol; 2023 Sep; 42(9):2279-2285. PubMed ID: 37270720
[TBL] [Abstract][Full Text] [Related]
5. Evans syndrome and systemic lupus erythematosus: clinical presentation and outcome.
Costallat GL; Appenzeller S; Costallat LT
Joint Bone Spine; 2012 Jul; 79(4):362-4. PubMed ID: 21944976
[TBL] [Abstract][Full Text] [Related]
6. Immune thrombocytopenia in systemic lupus erythematosus: Prevalence, risk factors, and a novel predictive model for risk assessment.
Cornudella Lema J; Sánchez-González B; Carrión-Barberà I; Vázquez Montes de Oca S; García Pallarols F; Salman-Monte TC
Med Clin (Barc); 2024 May; 162(10):461-469. PubMed ID: 38383267
[TBL] [Abstract][Full Text] [Related]
7. Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients.
Roussotte M; Gerfaud-Valentin M; Hot A; Audia S; Bonnotte B; Thibault T; Lobbes H; Le Guenno G; Goulabchand R; Cathebras P; Varron L; Dufour JF; Deroux A; Compain C; Baudet A; Karkowski L; Pérard L; Ebbo M; Lega JC; Sève P
Rheumatology (Oxford); 2022 Aug; 61(9):3627-3639. PubMed ID: 34918048
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune haemolytic anaemia and thrombocytopaenia in a single-centre cohort of patients with systemic lupus erythematosus from Turkey: clinical associations and effect on disease damage and survival.
Artım-Esen B; Çene E; Şahinkaya Y; Erdugan M; Oğuz E; Gül A; Öcal L; İnanç M
Lupus; 2019 Oct; 28(12):1480-1487. PubMed ID: 31558101
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Chock YP; Moulinet T; Dufrost V; Erkan D; Wahl D; Zuily S
Autoimmun Rev; 2019 Nov; 18(11):102395. PubMed ID: 31520800
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications and prognostic significance of thrombocytopenia in Tunisian patients with systemic lupus erythematosus.
Jallouli M; Frigui M; Marzouk S; Snoussi M; Kechaou M; Kaddour N; Masmoudi H; Elloumi M; Bahloul Z
Lupus; 2012 May; 21(6):682-7. PubMed ID: 22354537
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features of Systemic Lupus Erythematosus Patients Complicated With Evans Syndrome: A Case-Control, Single Center Study.
Zhang L; Wu X; Wang L; Li J; Chen H; Zhao Y; Zheng W
Medicine (Baltimore); 2016 Apr; 95(15):e3279. PubMed ID: 27082565
[TBL] [Abstract][Full Text] [Related]
12. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
[TBL] [Abstract][Full Text] [Related]
13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
14. Significance of autoimmune haemolytic anaemia and immune thrombocytopenia (Evans' syndrome) in systemic lupus erythematosus.
Pasangna J; Lim CB; Duraisamy G; Lajin I
Malays J Pathol; 1994 Jun; 16(1):79-82. PubMed ID: 16329581
[TBL] [Abstract][Full Text] [Related]
15. Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus.
Schmugge M; Revel-Vilk S; Hiraki L; Rand ML; Blanchette VS; Silverman ED
J Pediatr; 2003 Nov; 143(5):666-9. PubMed ID: 14615743
[TBL] [Abstract][Full Text] [Related]
16. Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients.
Paule R; Morel N; Le Guern V; Fredi M; Coutte L; Belhocine M; Mouthon L; le Jeunne C; Chauvin A; Piette JC; Costedoat-Chalumeau N
Autoimmun Rev; 2018 Sep; 17(9):866-872. PubMed ID: 30005859
[TBL] [Abstract][Full Text] [Related]
17. Childhood-onset systemic lupus erythematosus and immune thrombocytopenia: Prevalence and risk factors.
Kittivisuit S; Vachvanichsanong P; McNeil E; Chotsampancharoen T
Pediatr Blood Cancer; 2021 Aug; 68(8):e29146. PubMed ID: 34047041
[TBL] [Abstract][Full Text] [Related]
18. Cerebral Venous Sinus Thrombosis in Systemic Lupus Erythematosus.
Darmawan G; Hamijoyo L; Oehadian A; Bandiara R; Amalia L
Acta Med Indones; 2018 Oct; 50(4):343-345. PubMed ID: 30631001
[TBL] [Abstract][Full Text] [Related]
19. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
Ramos-Casals M; Campoamor MT; Chamorro A; Salvador G; Segura S; Botero JC; Yagüe J; Cervera R; Ingelmo M; Font J
Lupus; 2004; 13(10):777-83. PubMed ID: 15540510
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune hemolytic anemia in systemic lupus erythematosus: association with thrombocytopenia.
Domiciano DS; Shinjo SK
Clin Rheumatol; 2010 Dec; 29(12):1427-31. PubMed ID: 20473539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
